Literature DB >> 16328942

A Grid-based HIV expert system.

Peter M A Sloot1, Alexander V Boukhanovsky, Wilco Keulen, Alfredo Tirado-Ramos, Charles A Boucher.   

Abstract

OBJECTIVES: This paper addresses Grid-based integration and access of distributed data from infectious disease patient databases, literature on in-vitro and in-vivo pharmaceutical data, mutation databases, clinical trials, simulations and medical expert knowledge.
METHODS: Multivariate analyses combined with rule-based fuzzy logic are applied to the integrated data to provide ranking of patient-specific drugs. In addition, cellular automata-based simulations are used to predict the drug behaviour over time. Access to and integration of data is done through existing Internet servers and emerging Grid-based frameworks like Globus. Data presentation is done by standalone PC based software, Web-access and PDA roaming WAP access. The experiments were carried out on the DAS2, a Dutch Grid testbed.
RESULTS: The output of the problem-solving environment (PSE) consists of a prediction of the drug sensitivity of the virus, generated by comparing the viral genotype to a relational database which contains a large number of phenotype-genotype pairs.
CONCLUSIONS: Artificial Intelligence and Grid technology are effectively used to abstract knowledge from the data and provide the physicians with adaptive interactive advice on treatment applied to drug resistant HIV. An important aspect of our research is to use a variety of statistical and numerical methods to identify relationships between HIV genetic sequences and antiviral resistance to investigate consistency of results.

Entities:  

Mesh:

Year:  2005        PMID: 16328942     DOI: 10.1007/s10877-005-0673-2

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  4 in total

1.  Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

Authors:  J Durant; P Clevenbergh; P Halfon; P Delgiudice; S Porsin; P Simonet; N Montagne; C A Boucher; J M Schapiro; P Dellamonica
Journal:  Lancet       Date:  1999-06-26       Impact factor: 79.321

2.  Dynamics of HIV infection: a cellular automata approach.

Authors:  R M Zorzenon dos Santos; S Coutinho
Journal:  Phys Rev Lett       Date:  2001-09-26       Impact factor: 9.161

3.  Methods for investigation of the relationship between drug-susceptibility phenotype and human immunodeficiency virus type 1 genotype with applications to AIDS clinical trials group 333.

Authors:  A D Sevin; V DeGruttola; M Nijhuis; J M Schapiro; A S Foulkes; M F Para; C A Boucher
Journal:  J Infect Dis       Date:  2000-07-06       Impact factor: 5.226

4.  Antiretroviral-drug resistance among patients recently infected with HIV.

Authors:  Susan J Little; Sarah Holte; Jean-Pierre Routy; Eric S Daar; Marty Markowitz; Ann C Collier; Richard A Koup; John W Mellors; Elizabeth Connick; Brian Conway; Michael Kilby; Lei Wang; Jeannette M Whitcomb; Nicholas S Hellmann; Douglas D Richman
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

  4 in total
  3 in total

1.  New Approach to Privacy-Preserving Clinical Decision Support Systems for HIV Treatment.

Authors:  Gabriele Spini; Emiliano Mancini; Thomas Attema; Mark Abspoel; Jan de Gier; Serge Fehr; Thijs Veugen; Maran van Heesch; Daniël Worm; Andrea De Luca; Ronald Cramer; Peter M A Sloot
Journal:  J Med Syst       Date:  2022-10-20       Impact factor: 4.920

2.  Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection.

Authors:  Jeffrey A Anderson; Hongyu Jiang; Xiao Ding; Leslie Petch; Terri Journigan; Susan A Fiscus; Richard Haubrich; David Katzenstein; Ronald Swanstrom; Roy M Gulick
Journal:  AIDS Res Hum Retroviruses       Date:  2008-05       Impact factor: 2.205

3.  Computational systems biology in cancer: modeling methods and applications.

Authors:  Wayne Materi; David S Wishart
Journal:  Gene Regul Syst Bio       Date:  2007-09-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.